fbpx
Political and Legislative

FDA Schedules Meeting to Discuss Pharmaceutical Company’s First OTC Birth Control Pill Application

The Food and Drug Administration (FDA) has scheduled a joint meeting to discuss pharmaceutical company Perrigo’s application for what could be the first over-the-counter (OTC) daily birth control pill available in the U.S., the company announced Monday.

The joint meeting will be held on Nov. 18 with the FDA’s Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee, according to Perrigo.

If approved by the FDA, Perrigo’s progestin-only daily pill would be the first non-prescription birth control pill available in the U.S. Perrigo filed its application to move its birth control pill from prescription to OTC in July.

Read the source article at The Hill

Leave a Review or Comment

Back to top button